"So who wants what more - Amgen or Celgene ? and is there an impetus ?
I think someone has to move soon."
Sounds like a best case scenario for PAB:-)
PAB is not looking to licence (They say) but if they are approached by Celgene it's game on.
ann: data from final cohort of patients, page-37
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.001(7.69%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $17.34K | 2.497M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 6470626 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1004952 | 2 |
View Market Depth
| Last trade - 15.56pm 23/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |